StockData

Cartesian Therapeutics, Inc. (RNAC) stock

RNACNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$6.08−0.27 (-4.25%)

Close on Nov 16, 2026Market cap $183.95MP/E –Yield –

Earnings

Cartesian Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 8, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
–
– on a year earlier
EPS, Q3 FY2026
-$0.38
-$1.38 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Cartesian Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 8, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 5, 2026before the open––-$0.38Release
Q2 FY2026ended Jun 30, 2026Aug 6, 2026before the open––$0.46Release
Q1 FY2026ended Mar 31, 2026Apr 30, 2026before the open$78.00K-92.9%-$1.46Release
Q4 FY2025ended Dec 31, 2025Mar 9, 2026before the open–––Release
Q3 FY2025ended Sep 30, 2025Nov 6, 2025before the open$452.00K+16.8%-$1.38Release
Q2 FY2025ended Jun 30, 2025Aug 7, 2025before the open$298.00K-99.1%$0.50Release
Q1 FY2025ended Mar 31, 2025May 8, 2025before the open$1.10M-81.2%-$0.68Release
Q4 FY2024ended Dec 31, 2024Mar 13, 2025before the open–––Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024before the open$387.00K–-$1.13Release
Q2 FY2024ended Jun 30, 2024Aug 8, 2024before the open$33.45M+543.2%$0.54Release
Q1 FY2024ended Mar 31, 2024May 8, 2024before the open$5.84M–-$10.50Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Cartesian Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Cartesian Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Cartesian Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Update
  3. Results
  4. Update
  5. Update
  6. Update
  7. Results
  8. Results
  9. Update
  10. Update
  11. Update
  12. Update
  13. Update
  14. Results
  15. Update

See a number that looks wrong?